GEN Exclusives

More »

GEN News Highlights

More »
Sep 9, 2010

Ambry Confirmed as First U.S. CSP for NimbleGen Sequence-Capture Solution

  • Ambry Genetics has become the first Certified Service Provider (CSP) in the U.S. for NimbleGen's SeqCap EZ Exome sequence-capture technology. Status as a CSP means Ambry will be able to offer target-enrichment services using the SeqCap EZ Human Exome coupled with next-gen sequencing services for genetic research.
    The workflow will involve processing customer gDNA samples for genomic enrichment using 2.1 million optimized DNA probes from SeqCap EZ Exome, in order to capture all human coding exons, followed by sequencing using short-read, paired-end technology.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using Pet Dogs with Cancer in Preclinical Trials

Do you agree that pet dogs with cancer should be used in early cancer drug trials?

More »